These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 13481730)
1. The effect of group administration upon symptom formation under LSD. SLATER PE; MORIMOTO K; HYDE RW J Nerv Ment Dis; 1957; 125(2):312-5. PubMed ID: 13481730 [No Abstract] [Full Text] [Related]
3. [Model psychoses and their significance for an improved understanding of endogenous and exogenous psychoses]. HAASE HJ Med Klin; 1956 Nov; 51(44):1881-3. PubMed ID: 13386826 [No Abstract] [Full Text] [Related]
4. Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom. Malleson N Br J Psychiatry; 1971 Feb; 118(543):229-30. PubMed ID: 4995932 [No Abstract] [Full Text] [Related]
5. [Preliminary notes on the use of LSD 25 in the production of experimental psychoses]. FRAGOSO MENDES J Med Contemp; 1956 Dec; 74(12):565-70. PubMed ID: 13386654 [No Abstract] [Full Text] [Related]
6. [Antipheine and its effects on the course of LSD psychoses]. VINAR O Act Nerv Super (Praha); 1961 May; 3():211-2. PubMed ID: 13926054 [No Abstract] [Full Text] [Related]
7. [Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline]. VOJTECHOVSKY M; GROF S Cesk Psychiatr; 1960 Aug; 56():221-33. PubMed ID: 13781932 [No Abstract] [Full Text] [Related]
8. [A LSD-25 CLINICO-EXPERIMENTAL TEST AS AN ACCESSORY MEASURE IN DIFFERENTIAL DIAGNOSIS OF PSYCHOSES AND SIMULATED MENTAL DISORDERS]. TEMKOV I; BOIADZHIEVA M Suvr Med (Sofiia); 1964; 15():28-34. PubMed ID: 14273246 [No Abstract] [Full Text] [Related]
9. Prediction of syndromes under LSD-25. van REE F Fortschr Psychosom Med; 1960; 1():209-12. PubMed ID: 14436858 [No Abstract] [Full Text] [Related]
10. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990 [No Abstract] [Full Text] [Related]
11. THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY. BAKER EF Can Med Assoc J; 1964 Dec; 91(23):1200-2. PubMed ID: 14226093 [TBL] [Abstract][Full Text] [Related]
12. Some related factors of the LSD 25 reaction. SALVATORE S Psychiatr Q; 1960 Apr; 34():236-51. PubMed ID: 13745802 [No Abstract] [Full Text] [Related]
13. New blocking agent against the development of LSD-25 psychosis. FABING HD Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971 [No Abstract] [Full Text] [Related]
14. [ON THE VARIABILITY OF THE EFFECT OF DRUGS (PARTICULARLY WITH RESPECT TO THE EFFECT AND HAZARDS OF LSD ADMINISTRATION)]. DRVOTA S Act Nerv Super (Praha); 1963 May; 5():217-8. PubMed ID: 14073987 [No Abstract] [Full Text] [Related]
15. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis. FABING HD Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008 [No Abstract] [Full Text] [Related]
17. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989 [No Abstract] [Full Text] [Related]
18. [EFFECT OF NICOTINIC ACID ON EXPERIMENTAL PSYCHOSES INDUCED WITH LYSERGIC ACID DIETHYLAMIDE]. IVANOVA RA; MILSHTEIN GI; SMIRNOVA LB; FANCHENKO ND Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1172-6. PubMed ID: 14244572 [No Abstract] [Full Text] [Related]
19. The use of LSD-25 in the treatment of alcoholism and other psychiatric problems. MACLEAN JR; MACDONALD DC; BYRNE UP; HUBBARD AM Q J Stud Alcohol; 1961 Mar; 22():34-45. PubMed ID: 13764952 [No Abstract] [Full Text] [Related]
20. Effects of certain vitamins and histamines on the LSD psychosis. BERTINO JR; KLEE GD; WEINTRAUB W J Ment Sci; 1959 Oct; 105():1095-9. PubMed ID: 13799992 [No Abstract] [Full Text] [Related] [Next] [New Search]